Literature DB >> 33534375

Meibomian Gland Contrast Sensitivity and Specificity in the Diagnosis of Lipid-deficient Dry Eye: A Pilot Study.

Thao N Yeh1, Meng C Lin.   

Abstract

SIGNIFICANCE: Lipid deficiency due to meibomian gland (MG) dysfunction is believed to account for the vast majority of patients with dry eye compared with aqueous deficiency. Clinicians commonly evaluate MG length to determine a disease, but our research with isotretinoin users suggests that MG contrast is also an important characteristic to consider.
PURPOSE: This study aimed to determine the sensitivity and specificity of MG contrast for the diagnosis of lipid-deficient dry eye (LDDE).
METHODS: This case-control study used demographic data, Standard Patient Evaluation of Eye Dryness (SPEED) scores, average tear lipid layer thickness (TLLT), fluorescein tear breakup time (FTBUT), upper eyelid meibography images, and meibum quality and quantity scores for individuals with LDDE (SPEED score ≥10 and TLLT ≤35 interferometric color units) and normal individuals (SPEED ≤2 and TLLT ≥80 interferometric color units).
RESULTS: Thirty-one eyes of 22 controls (mean ± SD age, 22.7 ± 5.5 years) and 13 eyes of 12 cases (mean ± SD age, 43.9 ± 17.2 years) were included. Normalized MG contrast was significantly correlated with FTBUT (r = 0.35, P = .02), percent MG atrophy (r = -0.50, P < .001), and SPEED scores (r = -0.49, P < .001). The receiver operating characteristic curve for LDDE diagnosis classifiers MG contrast, MG atrophy, and meibum quantity score had areas under the curve of 0.83, 0.64, and 0.73, respectively. Meibomian gland contrast cutoff at 28.3 intensity units yielded optimal correct classification of subjects (84.1%; sensitivity, 0.69; specificity, 0.90). Cases had shorter FTBUT (P < .001), worse meibum quality (P = .02) and quantity (P = .02) scores, and lower MG contrast (P < .001) compared with controls. Subjects with low MG contrast (≤28.3) had 14.9 higher odds of having LDDE (95% confidence interval, 2.84 to 78.4) compared with subjects with high MG contrast (>28.3).
CONCLUSIONS: Meibomian gland contrast correlates well with clinical parameters and symptoms, shows good sensitivity and excellent specificity for diagnosing LDDE, and can be a useful diagnostic parameter for monitoring MG changes due to age, disease, or intervention.
Copyright © 2021 American Academy of Optometry.

Entities:  

Mesh:

Year:  2021        PMID: 33534375      PMCID: PMC7897301          DOI: 10.1097/OPX.0000000000001636

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   2.106


  24 in total

1.  Repeatability of Meibomian Gland Contrast, a Potential Indicator of Meibomian Gland Function.

Authors:  Thao N Yeh; Meng C Lin
Journal:  Cornea       Date:  2019-02       Impact factor: 2.651

2.  Morphological evaluation of meibomian glands using noncontact infrared meibography.

Authors:  Yumiko Ban; Seika Shimazaki-Den; Kazuo Tsubota; Jun Shimazaki
Journal:  Ocul Surf       Date:  2012-10-16       Impact factor: 5.033

3.  Human Lacrimal Production Rates from Modified Schirmer-Tear Test.

Authors:  Songhao Li; Young Hyun Kim; Wing Li; Meng C Lin; Clayton J Radke
Journal:  Optom Vis Sci       Date:  2018-04       Impact factor: 1.973

4.  Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.

Authors:  S C Pflugfelder; S C Tseng; O Sanabria; H Kell; C G Garcia; C Felix; W Feuer; B L Reis
Journal:  Cornea       Date:  1998-01       Impact factor: 2.651

5.  Clinical Outcomes Associated with Thermal Pulsation System Treatment.

Authors:  Pam Satjawatcharaphong; Shaokui Ge; Meng C Lin
Journal:  Optom Vis Sci       Date:  2015-09       Impact factor: 1.973

6.  Ocular surface changes and discomfort in patients with meibomian gland dysfunction.

Authors:  J Shimazaki; M Sakata; K Tsubota
Journal:  Arch Ophthalmol       Date:  1995-10

7.  Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls.

Authors:  Youngsub Eom; Jong-Suk Lee; Su-Yeon Kang; Hyo Myung Kim; Jong-Suk Song
Journal:  Am J Ophthalmol       Date:  2013-03-07       Impact factor: 5.258

Review 8.  Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

9.  Meibomian gland morphology and tear osmolarity: changes with Accutane therapy.

Authors:  W D Mathers; W J Shields; M S Sachdev; W M Petroll; J V Jester
Journal:  Cornea       Date:  1991-07       Impact factor: 2.651

10.  Risk factors for severe Meibomian gland atrophy in a young adult population: A cross-sectional study.

Authors:  Thao N Yeh; Meng C Lin
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

View more
  2 in total

1.  Evaluation of the Ocular Surface and Meibomian Gland in Obstructive Sleep Apnea Hypopnea Syndrome.

Authors:  Shaohua Liu; Shisheng Li; Mengmeng Li; Shiying Zeng; Baihua Chen; Liwei Zhang
Journal:  Front Med (Lausanne)       Date:  2022-02-09

2.  Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway.

Authors:  Peng Zhang; Lei Tian; Jiayu Bao; Shang Li; Ao Li; Ya Wen; Jingyi Wang; Ying Jie
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.